Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
The Journal of Clinical Psychiatry
|
September 19, 2017
Efficacy and Safety of the α7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers
George M Haig, Deli Wang, Jun Zhao, et al.
The American Journal of Psychiatry
|
March 5, 2016
A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia
George M Haig, Earle E Bain, Weining Z Robieson, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
March 19, 2011
Sex differences in the neural correlates of autonomic arousal: a pilot PET study
Allison C Nugent, Earle E Bain, Julian F Thayer, et al.
Journal of Clinical Pharmacology
|
December 5, 2015
Mitigating the Effects of Nonadherence in Clinical Trials
Thomas M Shiovitz, Earle E Bain, David J McCann, et al.
JMIR Mhealth and Uhealth
|
February 23, 2017
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
Earle E Bain, Laura Shafner, David P Walling, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 4, 2012
A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD
Earle E Bain, Weining Robieson, Yili Pritchett, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 9, 2013
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression
Allison C Nugent, Paul J Carlson, Earle E Bain, et al.
The Journal of Clinical Psychiatry
|
July 17, 2012
A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder
Earle E Bain, George Apostol, R Bart Sangal, et al.
Biological Psychiatry
|
July 27, 2005
Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy
Gregor Hasler, Alexander Neumeister, Jan Willem van der Veen, et al.
The American Journal of Psychiatry
|
November 3, 2005
Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder
Kristine Erickson, Wayne C Drevets, Luke Clark, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
The Journal of Clinical Psychiatry
|
September 19, 2017
Efficacy and Safety of the α7-Nicotinic Acetylcholine Receptor Agonist ABT-126 in the Treatment of Cognitive Impairment Associated With Schizophrenia: Results From a Phase 2b Randomized Controlled Study in Smokers
George M Haig, Deli Wang, Jun Zhao, et al.
The American Journal of Psychiatry
|
March 5, 2016
A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia
George M Haig, Earle E Bain, Weining Z Robieson, et al.
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology
|
March 19, 2011
Sex differences in the neural correlates of autonomic arousal: a pilot PET study
Allison C Nugent, Earle E Bain, Julian F Thayer, et al.
Journal of Clinical Pharmacology
|
December 5, 2015
Mitigating the Effects of Nonadherence in Clinical Trials
Thomas M Shiovitz, Earle E Bain, David J McCann, et al.
JMIR Mhealth and Uhealth
|
February 23, 2017
Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia
Earle E Bain, Laura Shafner, David P Walling, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 4, 2012
A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD
Earle E Bain, Weining Robieson, Yili Pritchett, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 9, 2013
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression
Allison C Nugent, Paul J Carlson, Earle E Bain, et al.
The Journal of Clinical Psychiatry
|
July 17, 2012
A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder
Earle E Bain, George Apostol, R Bart Sangal, et al.
Biological Psychiatry
|
July 27, 2005
Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy
Gregor Hasler, Alexander Neumeister, Jan Willem van der Veen, et al.
The American Journal of Psychiatry
|
November 3, 2005
Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder
Kristine Erickson, Wayne C Drevets, Luke Clark, et al.
Page
of 2